Capsugel® DRcaps™, HPMC based capsules developed by Capsugel, are well accepted non-animal acid resistant two piece hard capsules. Extending the time post-dosing at which drug is released from a capsule can potentially help sitespecific drug delivery. The aim of this study was to evaluate the benefit of Capsugel® DRcaps™ capsule acid resistance in a double capsule concept and extend the period of delayed release.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content
Latest briefing from the Knowledge Center